Product catalogue
Every compound held in the RSSE catalogue, with its CAS number, molecular formula and structure where available. Certificate of analysis issued per lot; quoted per enquiry.
706,747 products · 11780 pages
Products in this list
-
1-ethyl-2-(nitromethylene)pyrrolidine
CUSTOM SYNTHESIS -
3-ethoxy-4-methoxybenzoic acid
IN STOCK -
(E)-Cefcapene Pivoxil
BACK ORDER -
(E)-N-cyclopropylpropan-1-imine
CUSTOM SYNTHESIS -
1-Ethoxy-2-ethylbenzene
IN STOCK -
(E)-Hexa-3,5-dienoic acid
IN STOCK -
Etoposide
IN STOCK -
ethyl 4-(tert-butyl)benzenesulfonate
IN STOCK -
Etiracetam
IN STOCK -
Eltrombopag
IN STOCK -
Erythromycin B Oxime
BACK ORDER -
(7E,9Z)-ß-Ionylidene Acetaldehyde
CUSTOM SYNTHESIS -
Epirubicin Hydrochloride
IN STOCK -
2-ethylbutyl carbonochloridate
IN STOCK -
Brassicasterol Impurity 39
IN STOCK -
Valproate Sodium Impurity 5
IN STOCK -
Amisulpride Impurity 121
IN STOCK -
Ketoprofen Impurity 126
IN STOCK -
Enantiomers of (s, s) - formoterol
IN STOCK -
Amisulpride Impurity 173
CUSTOM SYNTHESIS -
Prednisone Impurity 35
CUSTOM SYNTHESIS -
Valproic Acid Impurity 165 (Mixture of E/Z-isomers)
CUSTOM SYNTHESIS -
(E)-10-Hexadecenal
IN STOCK -
Enalapril maleate
IN STOCK -
Epi Lovastatin
IN STOCK -
Nifedipine Impurity 47
IN STOCK -
Elagolix sodium
IN STOCK -
Esmolol Impurity 15
IN STOCK -
Empagliflozin
IN STOCK -
7-Ethyl-10-Methoxy Camptothecin
BACK ORDER -
Edaravone
IN STOCK -
(E)-Ajoene
CUSTOM SYNTHESIS -
(E)-Ceftibuten
BACK ORDER -
Esmolol Dimer Reference
IN STOCK -
9-epi-Artemisinin
IN STOCK -
(2E)-4-Bromo-2-buten-1-ol
IN STOCK -
Ertugliflozin
IN STOCK -
2’-Epi-DCT II Impurity
BACK ORDER -
Epalrestat (Z, Z)-Isomer
IN STOCK
706,747 products · 11780 pages


































![Chemical structure of 1-{[2-(4-Ethylphenyl)-5-methyl-1,3-oxazol-4-yl]-methyl}piperidine-4-carboxylic acid](/structures/w4/UJXZFYVVLYBLLR-UHFFFAOYSA-N.webp?v=7)



![Chemical structure of 8-(4-Ethoxyphenyl)-2,6,7,8-tetrahydroimidazo[2,1-c][1,2,4]triazine-3,4-dione](/structures/w4/OAVARTGKOTYGGA-UHFFFAOYSA-N.webp?v=7)

![Chemical structure of (1-{[4-(Ethoxycarbonyl)-3,5-dimethyl-1H-pyrrol-2-yl]carbonyl}piperidin-4-yl)acetic acid](/structures/w4/VAXZZRPJIAZVHL-UHFFFAOYSA-N.webp?v=7)
![Chemical structure of [{2-[4-(Ethoxycarbonyl)piperazin-1-yl]-2-oxoethyl}(4-methoxyphenyl)amino]acetic acid](/structures/w4/FVMNLZZJTNOWGN-UHFFFAOYSA-N.webp?v=7)
![Chemical structure of [{2-[4-(Ethoxycarbonyl)piperidin-1-yl]-2-oxoethyl}(4-methoxyphenyl)amino]acetic acid](/structures/w4/QESVNQYGNVMRSG-UHFFFAOYSA-N.webp?v=7)
![Chemical structure of [{2-[3-(Ethoxycarbonyl)piperidin-1-yl]-2-oxoethyl}(4-methoxyphenyl)amino]acetic acid](/structures/w4/AHSAUZJKVPQNAD-UHFFFAOYSA-N.webp?v=7)
![Chemical structure of [{2-[4-(Ethoxycarbonyl)piperazin-1-yl]-2-oxoethyl}(phenyl)amino]acetic acid](/structures/w4/KIXJFPBHDUBIER-UHFFFAOYSA-N.webp?v=7)
![Chemical structure of 1-{3-[5-(Ethoxycarbonyl)-2,4-dimethyl-1H-pyrrol-3-yl]propanoyl}piperidine-4-carboxylic acid](/structures/w4/SHRUXHHMCQWNQW-UHFFFAOYSA-N.webp?v=7)
![Chemical structure of ({[5-({[4-(Ethoxycarbonyl)phenyl]amino}carbonyl)-1,3,4-thiadiazol-2-yl]methyl}thio)acetic acid](/structures/w4/FMQWNGMJMIEASV-UHFFFAOYSA-N.webp?v=7)
![Chemical structure of (1-{[5-(Ethoxycarbonyl)-2,4-dimethyl-1H-pyrrol-3-yl]carbonyl}piperidin-4-yl)acetic acid](/structures/w4/PSSFUZHPMXENQG-UHFFFAOYSA-N.webp?v=7)
![Chemical structure of 1-{[4-(Ethoxycarbonyl)-3,5-dimethyl-1H-pyrrol-2-yl]carbonyl}piperidine-3-carboxylic acid](/structures/w4/YHOVAULAUBWDJA-UHFFFAOYSA-N.webp?v=7)
![Chemical structure of [{2-[4-(Ethoxycarbonyl)piperidin-1-yl]-2-oxoethyl}(phenyl)amino]acetic acid](/structures/w4/YHYVNERFANGODE-UHFFFAOYSA-N.webp?v=7)
![Chemical structure of [{2-[3-(Ethoxycarbonyl)piperidin-1-yl]-2-oxoethyl}(phenyl)amino]acetic acid](/structures/w4/MYMXXLQIEWFGRX-UHFFFAOYSA-N.webp?v=7)




![Chemical structure of 7-[3-(Ethylamino)phenyl]pyrazolo[1,5-a]pyrimidin-3-carboxamide](/structures/w4/INRWFWSYVIFUCE-XXDHJSDNSA-N.webp?v=7)

![Chemical structure of (E)-1-[4-(dimethylamino)phenyl]-3-(4-nitrophenyl)prop-2-en-1-one](/structures/w4/GUTSWDYMYNLJEK-LFYBBSHMSA-N.webp?v=7)
